Workflow
2025年限制性股票激励计划限制性股票
icon
Search documents
赛福天: 关于向2025年限制性股票激励计划激励对象授予限制性股票的公告
Zheng Quan Zhi Xing· 2025-08-26 17:08
证券代码:603028 证券简称:赛福天 公告编号:2025-046 江苏赛福天集团股份有限公司 关于向 2025 年限制性股票激励计划激励对象 授予限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要提示内容: ? 限制性股票授予日:2025 年 8 月 25 日 ? 限制性股票授予数量:293 万股 ? 限制性股票授予价格:5.11 元/股 江苏赛福天集团股份有限公司(以下简称"公司")于 2025 年 8 月 25 日召 开第五届董事会第十八次会议,审议通过了《关于向 2025 年限制性股票激励计划激 励对象授予限制性股票的议案》,现将《江苏赛福天集团股份有限公司 2025 年限 制性股票激励计划》(以下简称"本次激励计划"或"本激励计划"或"《激励 计划》")授予的有关事项进行如下说明: 一、本次激励计划权益授予情况 (一)已履行的决策程序和信息披露情况 于公司<2025 年限制性股票激励计划(草案)>及其摘要的议案》等议案。董事 会薪酬与考核委员会对本激励计划的相关事项进行了核查并出具了相关核 ...
东睦股份: 东睦股份第九届董事会第三次会议决议公告
Zheng Quan Zhi Xing· 2025-08-25 16:52
证券代码:600114 股票简称:东睦股份 编号:2025-082 NBTM NEW MATERIALS GROUP Co., Ltd. 东睦新材料集团股份有限公司 第九届董事会第三次会议决议公告 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上 市公司股权激励管理办法》等有关法律、法规和规范性文件以及《公司章 程》的规定,董事会审议了《关于公司2025年限制性股票激励计划限制性 股票授予相关事项的议案》,公司董事会认为公司2025年限制性股票激励 计划限制性股票的授予条件已成就。根据公司2025年第三次临时股东会的 授权,董事会同意以2025年8月22日为公司2025年限制性股票激励计划授 证券代码:600114 股票简称:东睦股份 编号:2025-082 予日,同意向304名激励对象授予1,500万股限制性股票,授予价格为 因董事朱志荣、芦德宝、多田昌弘、郭灵光作为公司2025年限制性股 票激励计划的激励对象,已对本议案进行了回避表决。 表决结果:赞成5票,反对0票,弃权0票,表决通过。 本议案事前已经公司第九届董事会薪酬与考核委员会第二次会议审议 通过并发表了核查意见。具体内容详见公司于20 ...
和元生物: 第四届董事会第二次会议决议公告
Zheng Quan Zhi Xing· 2025-07-23 10:17
Group 1 - The company held its fourth board meeting on July 22, 2025, which was an emergency meeting attended by all nine directors and senior management [1] - The board approved the proposal for the initial grant of restricted stock under the 2025 Restricted Stock Incentive Plan, with a grant date of July 22, 2025, and a grant price of 3.09 yuan per share [1] - A total of 2,996,400 shares of restricted stock will be granted to 61 eligible incentive recipients [1] Group 2 - The proposal was reviewed and approved by the company's Compensation and Assessment Committee during its second meeting [2] - Related directors recused themselves from the voting process, resulting in a vote of 4 in favor, 0 abstentions, and 0 against [2]
西力科技: 杭州西力智能科技股份有限公司第三届监事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-05-20 13:13
Group 1 - The company held its 12th meeting of the third supervisory board on May 20, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1] - The supervisory board approved the proposal to grant restricted stock to 81 eligible participants under the 2025 restricted stock incentive plan, with a grant price of 5.54 yuan per share for a total of 3.1 million shares [2] - The board confirmed that the conditions for the incentive plan had been met and that the grant date was set for May 20, 2025, in accordance with relevant regulations [2]
万邦医药: 第二届监事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-05-13 11:17
Group 1 - The company held its 12th meeting of the second Supervisory Board on May 13, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2] - The Supervisory Board approved the proposal for the initial grant of restricted stock under the 2025 incentive plan, confirming that the conditions for granting and the eligibility of the incentive objects were met [1][2] - A total of 509,375 restricted shares will be granted to 88 incentive objects at a price of 19.75 yuan per share, with the grant date set as May 13, 2025 [2]